KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abercrombie & Fitch (ANF) EBITDA (2016 - 2025)

Historic EBITDA for Abercrombie & Fitch (ANF) over the last 17 years, with Q4 2025 value amounting to $119.9 million.

  • Abercrombie & Fitch's EBITDA fell 1145.49% to $119.9 million in Q4 2025 from the same period last year, while for Nov 2025 it was $530.3 million, marking a year-over-year decrease of 325.23%. This contributed to the annual value of $570.8 million for FY2025, which is 6940.07% up from last year.
  • As of Q4 2025, Abercrombie & Fitch's EBITDA stood at $119.9 million, which was down 1145.49% from $146.6 million recorded in Q3 2025.
  • In the past 5 years, Abercrombie & Fitch's EBITDA registered a high of $184.0 million during Q1 2025, and its lowest value of -$25.2 million during Q2 2022.
  • Moreover, its 5-year median value for EBITDA was $81.1 million (2021), whereas its average is $78.7 million.
  • In the last 5 years, Abercrombie & Fitch's EBITDA skyrocketed by 81734.47% in 2021 and then plummeted by 15714.16% in 2022.
  • Over the past 5 years, Abercrombie & Fitch's EBITDA (Quarter) stood at $47.9 million in 2021, then plummeted by 130.17% to -$14.4 million in 2022, then soared by 792.12% to $99.9 million in 2023, then surged by 35.48% to $135.4 million in 2024, then dropped by 11.45% to $119.9 million in 2025.
  • Its last three reported values are $119.9 million in Q4 2025, $146.6 million for Q3 2025, and $79.9 million during Q2 2025.